Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (2): 126-129,133    DOI: 10.19485/j.cnki.issn2096-5087.2023.02.008
  综述 本期目录 | 过刊浏览 | 高级检索 |
骨科术后患者排便障碍的影响因素及干预研究进展
倪晶1, 马超猛1, 项思成1, 贾翁萍1, 张燕1 综述, 徐利2 审校
1.浙江中医药大学第一临床医学院,浙江 杭州 310053;
2.浙江中医药大学附属第一医院,浙江 杭州 310006
Influencing factors and interventions of defecation disorders after orthopedic surgery: a review
NI Jing1, MA Chaomeng1, XIANG Sicheng1, JIA Wengping1, ZHANG Yan1, XU Li2
1. The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China;
2. The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, China
全文: PDF(893 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 排便障碍是骨科术后最常见的并发症之一,可严重影响患者生活质量。本文通过查阅近年来关于术后排便障碍影响因素及干预的国内外文献,分析骨科手术相关因素与术后排便障碍的关系,并从药物治疗、物理治疗及日常生活管理等方面总结术后排便障碍的常用干预方法,为骨科术后患者排便障碍的预防及干预提供参考。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
倪晶
马超猛
项思成
贾翁萍
张燕
徐利
关键词 骨科手术排便障碍影响因素阿片类药物干预    
Abstract:Defecation disorder is one of the most common complications after orthopedic surgery, which seriously affects patients' quality of life. Based on review of national and international publications pertaining to influencing factors and interventions of postoperative defecation disorders, this review analyzes the associations of orthopedic surgery-related factors with postoperative defecation disorders, and summarizes the common interventions for postoperative defecation disorders, including medication, physical therapy and daily life management, so as to provide insights into prevention and treatment of defecation disorders after orthopedic surgery.
Key wordsorthopedic surgery    defecation disorder    influencing factor    opioids    intervention
收稿日期: 2022-09-26      出版日期: 2023-02-21
中图分类号:  R816.8  
基金资助:国家自然科学基金(81704082); 浙江省医药卫生科技项目(2020384124)
通信作者: 徐利,E-mail:20053012@zcmu.edu.cn   
作者简介: 倪晶,硕士研究生在读
引用本文:   
倪晶, 马超猛, 项思成, 贾翁萍, 张燕, 徐利. 骨科术后患者排便障碍的影响因素及干预研究进展[J]. 预防医学, 2023, 35(2): 126-129,133.
NI Jing, MA Chaomeng, XIANG Sicheng, JIA Wengping, ZHANG Yan, XU Li. Influencing factors and interventions of defecation disorders after orthopedic surgery: a review. Preventive Medicine, 2023, 35(2): 126-129,133.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.02.008      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I2/126
[1] ROSS-ADJIE G M,MONTEROSSO L,BULSARA M.Bowel management post major joint arthroplasty:results from a randomised controlled trial[J].Int J Orthop Trauma Nurs,2015,19(2):92-101.
[2] 颜廷法,李倩倩,孙飞,等.关节置换患者术后便秘的相关因素分析[J].泰山医学院学报,2019,40(7):505-508.
[3] 陈巧林. 关节置换患者术后便秘的相关因素与护理对策[J].中国社区医师,2017,33(21):145-146.
[4] PODZEMNY V,PESCATORI L C,PESCATORI M.Management of obstructed defecation[J].World J Gastroenterol,2015,21(4):1053-1060.
[5] HOLTE K,KEHLET H.Postoperative ileus:a preventable event[J].Br J Surg,2000,87(11):1480-1493.
[6] MCCORMICK D.Managing costs and care for chronic idiopathic constipation[J].Am J Manag Care,2019,25(Suppl.4):S63-S69.
[7] ARTINYAN A,NUNOO-MENSAH J W,BALASUBRAMANIAM S,et al.Prolonged postoperative ileus-definition,risk factors,and predictors after surgery[J].World J Surg,2008,32(7):1495-1500.
[8] 刘菊新. 骨科长期卧床病人便秘原因的分析与对策[J].长治医学院学报,2004(1):64-65.
[9] FARMER A D,HOLT C B,DOWNES T J,et al.Pathophysiology,diagnosis,and management of opioid-induced constipation[J].Lancet Gastroenterol Hepatol,2018,3(3):203-212.
[10] 刘立波,陈朝军,凌洁.骨科卧床病人便秘原因分析及护理对策[J].湖南师范大学学报(医学版),2010,7(3):72-74.
[11] KIELY P D,MOUNT L E,DU J Y,et al.The incidence and risk factors for post-operative ileus after spinal fusion surgery:a multivariate analysis[J].Int Orthop,2016,40(6):1067-1074.
[12] AL MAAIEH M A,DU J Y,AICHMAIR A,et al.Multivariate analysis on risk factors for postoperative ileus after lateral lumbar interbody fusion[J].Spine,2014,39(8):688-694.
[13] 唐雨亭,方立俭.骶神经刺激疗法治疗便秘的现状及机制探讨[J].吉林医学,2018,39(4):745-748.
[14] HOLZER P.Opioid receptors in the gastrointestinal tract[J].Regul Pept,2009,155(1/2/3):11-17.
[15] CHEN C,ZHANG L,ALMANSA C,et al.Evaluation of the pharmacokinetics of felcisetrag(TAK-954),a 5-HT4 receptor agonist,in the presence and absence of itraconazole,a potent CYP3A4 inhibitor[J].Clin Pharmacol Drug Dev,2022,11(2):142-149.
[16] BENYAMIN R,TRESCOT A,DATTA S,et al.Opioid complications and side effects[J].Pain Physician,2008,11:S105-S120.
[17] COLVIN L A,BULL F,HALES T G.Perioperative opioid analgesia-when is enough too much?A review of opioid-induced tolerance and hyperalgesia[J].Lancet,2019,393(10180):1558-1568.
[18] SINGLA N K,SKOBIERANDA F,SOERGEL D G,et al.APOLLO-2:a Randomized,Placebo and Active-Controlled Phase Ⅲ study investigating oliceridine(TRV130),a G protein-biased ligand at the μ-opioid receptor,for management of moderate to severe acute pain following abdominoplasty[J].Pain Practice,2019,19(7):715-731.
[19] LEPPERT W,ZAJACZKOWSKA R,WORDLICZEK J.The role of oxycodone/naloxone in the management of patients with pain and opioid-induced constipation[J].Expert Opin Pharmacother,2019,20(5):511-522.
[20] YUAN C S,FOSS J F.Methylnaltrexone:investigation of clinical applications[J].Drug Dev Res,2000,50(2):133-141.
[21] FLOETTMANN E,BUI K,SOSTEK M,et al.Pharmacologic profile of naloxegol,a peripherally acting µ-opioid receptor antagonist,for the treatment of opioid-induced constipation[J].J Pharmacol Exp Ther,2017,361(2):280-291.
[22] 韦良臣,谭振,周报春,等.莫沙必利联合地塞米松对全膝关节置换术术后早期康复的影响[J].中华实用诊断与治疗杂志,2021,35(12):1285-1289.
[23] SWARM R A,PAICE J A,ANGHELESCU D L,et al.Adult cancer pain,version 3.2019,NCCN clinical practice guidelines in oncology[J/OL].J Natl Compr Canc Netw,2019,17(8)[2022-12-17].https://doi.org/10.6004/jnccn.2019.0038.
[24] LACY B E,LEVY L C.Lubiprostone:a novel treatment for chronic constipation[J].Clin Interv Aging,2008,3(2):357-364.
[25] LEMBO A J,JOHANSON J F,PARKMAN H P,et al.Long-term safety and effectiveness of lubiprostone,a chloride channel(ClC-2)activator,in patients with chronic idiopathic constipation[J].Dig Dis Sci,2011,56(9):2639-2645.
[26] SHAH E D,KIM H M,SCHOENFELD P.Efficacy and tolerability of guanylate cyclase-c agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation:a systematic review and meta-analysis[J].Am J Gastroenterol,2018,113(3):329-338.
[27] NAKAJIMA A,TANIGUCHI S,KUROSU S,et al.Efficacy,long-term safety,and impact on quality of life of elobixibat in more severe constipation:post hoc analyses of two phase 3 trials in Japan[J/OL].Neurogastroenterol Motil,2019,31(5)[2022-12-02].https://doi.org/10.1111/nmo.13571.
[28] HUSSAIN Z H,WHITEHEAD D A,LACY B E.Fecal Impaction[J/OL].Curr Gastroenterol Rep,2014,16(9)[2022-12-02].https://doi.org/10.1007/s11894-014-0404-2.
[29] MORI H,TACK J,SUZUKI H.Magnesium oxide in constipation[J/OL].Nutrients,2021,13(2)[2022-12-02].https://doi.org/10.3390/nu13020421.
[30] RAO S S.Biofeedback therapy for constipation in adults[J].Best Pract Res Clin Gastroenterol,2011,25(1):159-166.
[31] ZHOU S L,ZHANG X L,WANG J H.Comparison of electroacupuncture and medical treatment for functional constipation:a systematic review and meta-analysis[J].Acupunct Med,2017,35(5):324-331.
[32] 于凌. 针灸治疗胸腰椎骨折术后腹胀便秘的临床疗效[J].中外女性健康研究,2018(12):28-29.
[33] BAE S H.Diets for constipation[J].Pediatric Gastroenterol Hepatol Nutr,2014,17(4):203-208.
[34] ROSENBAUM D P,YAN A,JACOBS J W.Pharmacodynamics,safety,and tolerability of the NHE3 inhibitor tenapanor:two trials in healthy volunteers[J].Clin Drug Investig,2018,38(4):341-351.
[35] CAMILLERI M,FORD A C,MAWE G M,et al.Chronic constipation[J/OL].Nat Rev Dis Primers,2017,3(1)[2022-12-02].https://doi.org/10.1038/nrdp.2017.95.
[1] 张丛笑, 郑琳, 沈利明, 黄闽燕, 陈晖, 牛星凯, 宋凯. 西湖区中小学生抑郁症状调查[J]. 预防医学, 2023, 35(3): 196-199.
[2] 余繁荣, 王伟, 闫玉琴, 宋黎桥, 陈莉媛, 苏少晨. 玛曲县藏族小学生患龋的影响因素分析[J]. 预防医学, 2023, 35(3): 239-242.
[3] 谢睿, 胡菊莲, 喻喆. 妊娠糖尿病患者生活质量的影响因素研究[J]. 预防医学, 2023, 35(2): 162-165.
[4] 王婷婷, 李馨. 育龄期女性卵巢储备功能下降的影响因素分析[J]. 预防医学, 2023, 35(2): 158-161.
[5] 韩俊丽, 刘洋, 高大维, 孙婕, 徐鹏鹏, 龚天麒, 胡颉颖, 曹艳宏, 吕勇. 耶尔森菌病危险因素的病例对照研究[J]. 预防医学, 2023, 35(2): 93-98.
[6] 杨秀琳, 马宗康, 马霞, 马鑫. 东乡族自治县农村居民传染病健康素养调查[J]. 预防医学, 2023, 35(2): 166-170.
[7] 陈丽燕, 高玲一. 变应性鼻炎患儿免疫治疗家庭干预效果评价[J]. 预防医学, 2023, 35(1): 83-86.
[8] 姜佳佳, 李峰, 房冬冬, 尤文君, 王伟伟. 2型糖尿病患者非增殖型糖尿病性视网膜病变的影响因素分析[J]. 预防医学, 2023, 35(1): 17-20.
[9] 常进科, 张俊绘, 赵文芳, 刘爱菊. 孕妇体重自我管理动机水平的影响因素分析[J]. 预防医学, 2022, 34(9): 946-950.
[10] 孙楷城, 陈劲华, 朱志宏, 黄葵青, 傅爽. 义乌市小学生营养综合干预效果评价[J]. 预防医学, 2022, 34(9): 964-967.
[11] 余红, 陈晓霞, 吴长划, 沈沛. 早产儿体格生长和神经发育的早期综合干预效果评价[J]. 预防医学, 2022, 34(8): 771-775.
[12] 沈婷, 蔡永环, 张静敏, 胡艺俨, 靳颖, 许俊. 西湖区健康促进学校初中学生电子烟使用调查[J]. 预防医学, 2022, 34(8): 776-781.
[13] 贾娟娟, 林云, 朱国英, 洪霞, 孙炀明, 何海涛, 陈丽艳, 李赟. 嘉兴市中小学生脊柱侧弯调查[J]. 预防医学, 2022, 34(8): 782-787.
[14] 孔琳姝, 李明津, 麻珂, 刘宇. 老年慢性病患者照顾者负担的影响因素分析[J]. 预防医学, 2022, 34(7): 700-704.
[15] 杨丹丹, 姚学成, 张昕涵, 唐梦龄, 王建炳, 金明娟, 陈坤. 中国人群胃癌发病影响因素的Meta分析[J]. 预防医学, 2022, 34(6): 561-570.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed